These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38819248)

  • 1. Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature.
    Deka A; Joseph E; Sharma N; Berhanu T; Kaplan J
    J Psychiatr Pract; 2024 May; 30(3):234-241. PubMed ID: 38819248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: Treatment-resistant Depression: Considerations Related to ECT and Ketamine.
    Garakani A
    J Psychiatr Pract; 2021 Nov; 27(6):496-497. PubMed ID: 34768276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine and electroconvulsive therapy: so happy together?
    Cobb K; Nanda M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):459-462. PubMed ID: 29794567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
    Zhang J; Tian H; Li J; Ji S; Chen S; Zhu J; Jiang D; Wang L; Li G; Chen M; Wang W; Lin X; Zhuo C
    Psychiatry Res; 2020 May; 287():112907. PubMed ID: 32179210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin syndrome after electroconvulsive therapy in a patient on trazodone, bupropion, and quetiapine: a case report.
    Cheng YC; Liang CM; Liu HC
    Clin Neuropharmacol; 2015; 38(3):112-3. PubMed ID: 25970280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.
    Wang X; Chen Y; Zhou X; Liu F; Zhang T; Zhang C
    J ECT; 2012 Jun; 28(2):128-32. PubMed ID: 22622291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.
    Gonçalves CL; Abelaira HM; Rosa T; de Moura AB; Veron DC; Borba LA; Botelho MEM; Goldim MP; Garbossa L; Fileti ME; Petronilho F; Ignácio ZM; Quevedo J; Réus GZ
    Pharmacol Rep; 2021 Apr; 73(2):525-535. PubMed ID: 33393059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Low Dose of Ketamine on Learning Memory Function in Patients Undergoing Electroconvulsive Therapy-A Randomized, Double-Blind, Controlled Clinical Study.
    Chen Q; Min S; Hao X; Peng L; Meng H; Luo Q; Chen J; Li X
    J ECT; 2017 Jun; 33(2):89-95. PubMed ID: 27828927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
    Ekstrand J; Fattah C; Persson M; Cheng T; Nordanskog P; Åkeson J; Tingström A; Lindström MB; Nordenskjöld A; Movahed Rad P
    Int J Neuropsychopharmacol; 2022 May; 25(5):339-349. PubMed ID: 35020871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.
    Kranaster L; Kammerer-Ciernioch J; Hoyer C; Sartorius A
    Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):575-82. PubMed ID: 21400226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.
    Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R
    J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study.
    Järventausta K; Chrapek W; Kampman O; Tuohimaa K; Björkqvist M; Häkkinen H; Yli-Hankala A; Leinonen E
    J ECT; 2013 Sep; 29(3):158-61. PubMed ID: 23475029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S -ketamine compared to etomidate during electroconvulsive therapy in major depression.
    Zavorotnyy M; Kluge I; Ahrens K; Wohltmann T; Köhnlein B; Dietsche P; Dannlowski U; Kircher T; Konrad C
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):803-813. PubMed ID: 28424861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.